SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2010 / Cilt: 10 - Sayı: 5

The levels of the leptin and adiponectin according to body mass index and their relationship with oxidative parameters

Vücut kütle indeksine göre leptin ve adiponektin seviyeleri ve bunların oksidatif parametrelerle ilişkisi

Ali YILDIZ
Onur AKPINAR
Recep DEMİRBAĞ
Yusuf SEZEN
Nihat SÖYLEMEZ
Pages
391–396
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Methods: A total of 87 healthy individuals with BMI >35 kg/m2 (n=29, Group 1), BMI=25-35 kg/m2 (n=29, Group 2) and BMI

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective:Obesity is an important risk factor of atherosclerosis and its prevalence in humans is increasing.
📊
Key Findings & Data:Recent studies suggest that the leptin and adiponectin play important roles in obesity, and they are associated with complications of obesity.
💡
Conclusion & Impact:Methods: A total of 87 healthy individuals with BMI >35 kg/m2 (n=29, Group 1), BMI=25-35 kg/m2 (n=29, Group 2) and BMI
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective:Obesity is an important risk factor of atherosclerosis and its prevalence in humans is increasing. Recent studies suggest that the leptin and adiponectin play important roles in obesity, and they are associated with complications of obesity. However, the mechanism of effects has not been outstandingly established. In this study, we studied leptin and adiponectin levels according to body mass index (BMI) and their relationship with oxidative parameters. Methods: A total of 87 healthy individuals with BMI >35 kg/m2 (n=29, Group 1), BMI=25-35 kg/m2 (n=29, Group 2) and BMI

Özet

Amaç:Obezite ateroskleroz için önemli bir risk faktörüdür ve sıklığı hızla artmaktadır. Son çalışmalar obezitede ve obezite ile ilişkili komplikasyonlarda leptin ve adiponektinin önemli rol oynadığını düşündürtmektedir. Bununla birlikte etki mekanizmaları tam olarak ortaya konulamamıştır. Bu çalışmada leptin ve adiponektin düzeylerinin vücut kütle indeksi (VKİ) ve oksidatif parametreler ile olan ilişkisi araştırıldı. Yöntemler: Enine-kesitli gözlemsel çalışmaya sağlıklı bireyler arasında VKİ ölçütlerine göre VKİ >35 kg/m2 olan (n=29, Grup 1), VKİ = 25–30 kg/m2 arası (n=29, Grup 2) ve VKİ

🔖

Cite This Article

YILDIZ, A., AKPINAR, O., DEMİRBAĞ, R., SEZEN, Y., SÖYLEMEZ, N. (2022). The levels of the leptin and adiponectin according to body mass index and their relationship with oxidative parameters. Anadolu Kardiyoloji Dergisi, Cilt: 10 - Sayı: 5, 391–396. https://ajindex.com/articles/436734

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002; 60: S1-14
  2. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26: 1407-33
  3. Ren J. Leptin and hyperleptinemia from friend to for cardiovascular function. J Endocrinol 2004; 181: 1-10 4. Kartal O, İnal V, Baysan O, Sağlam K. Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients. Anadolu Kardiyol Derg 2008; 8: 342-6
  4. Bilgili S, Çelebiler AC, Doğan A, Karaca B. Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr Regul 2008; 42: 63-8
  5. Göksoy H, Dursunoğlu D, Öztürk M, Rota S. The association between serum adiponectin levels and the severity of coronary artery lesions on the angiogram. Türk Kardiyol Dern Arş 2009; 37: 241-5
  6. Kolotkin RL, Meter K, Wiliams GR. Health related quality of life and obesity. Obes Rev 2001; 2: 219-29
  7. Rohner-Jeanrenaud F. A neuroendocrine reappraisal of the dual-center hypothesis: its implications for obesity and insulin resistance. Int J Obes Relat Metab Disord 1995; 19: 517-34
  8. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1997; 337: 396-407
  9. Cros CE, Halliwell B, Borish E, Pryor WA, Ames BN, Saul RL, et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-45
  10. McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993; 26: 351-7
  11. Demirbağ R, Yılmaz R, Gür M, Çelik H, Güzel S, Selek S, et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract 2006; 60: 1187-93
  12. Galili O, Versari D, Sattler KJ, Olson ML, Mannheim D, McConnell JP, et al. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 2007; 292: H904-11
  13. Beltowski J, Wójcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.Atherosclerosis 2003;170:21-9
  14. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 20